| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT01375400 | Ischemic Stroke | Drug: Aspirin|Biological: blood sample | Central Hospital, Nancy, France | | 2010-12-01 | 2011-06-20 |
| NCT01597375 | Asthma, Aspirin-Induced|Aspirin Exacerbated Asthma | Drug: Prasugrel | Elliot Israel, MD|Brigham and Women's Hospital | | 2012-08-01 | 2017-01-04 |
| NCT02409680 | Premature Birth | Drug: Low dose aspirin|Drug: Placebo | NICHD Global Network for Women's and Children's Health|Thomas Jefferson University|KLE University's Jawaharlal Nehru Medical College | | 2016-03-01 | 2016-12-15 |
| NCT02158806 | Venous Leg Ulcer | Drug: Aspirin|Drug: Placebo | University of Auckland, New Zealand|Health Research Council, New Zealand | Phase 3 | 2015-03-01 | 2016-05-10 |
| NCT03049085 | Coronary Artery Disease|Aspirin | Drug: Aspirin|Drug: vitamin C | Medinet Heart Centre | Phase 4 | 2017-02-01 | 2017-02-07 |
| NCT01361620 | Platelet Dysfunction Due to Aspirin | Drug: aspirin | George Washington University | | 2007-12-01 | 2013-10-29 |
| NCT01353144 | Peptic Ulcer | Drug: aspirin | Kaohsiung Veterans General Hospital. | Phase 4 | 2007-06-01 | 2016-09-12 |
| NCT02301286 | Colon Cancer|Adjuvant Therapy | Drug: Acetylsalicylic acid|Drug: Placebo Acetylsalicylic acid | Leiden University Medical Center|Stichting voor Patienten met Kanker aan het Spijsverteringskanaal (SPKS)|Dutch Colorectal Cancer Group|Stichting Geriatrische Oncologie Nederland (GeriOnNe)|Fonds NutsOhra|Innovatiefonds Zorgverzekeraars|Anticancer Fund, Belgium | Phase 3 | 2014-09-01 | 2016-03-16 |
| NCT02895113 | Diabetes | Drug: Aspirin|Other: Placebo | University of Roma La Sapienza | Phase 3 | 2017-01-01 | 2016-09-08 |
| NCT00470561 | Mammographic Breast Density | Drug: Aspirin|Drug: Placebo | Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI) | | 2005-11-01 | 2010-11-10 |
| NCT00948987 | Aspirin Resistance|Pharmacological Aspirin Non-responsiveness | Drug: Aspirin | University of Pennsylvania|National Institutes of Health (NIH)|Bayer | Phase 1 | 2004-09-01 | 2009-10-14 |
| NCT02350543 | Hematuria|Urinary Bladder Neoplasms | Drug: Aspirin | Rabin Medical Center | Phase 4 | 2015-02-01 | 2016-10-08 |
| NCT00818337 | Heart Disease | Drug: Aspirin | Creighton University | Phase 4 | 2008-11-01 | 2012-11-06 |
| NCT02084615 | Hernia, Inguinal|Postoperative Complications|Postoperative Hemorrhage | Drug: Aspirin | Jesse Brown VA Medical Center | | 2014-08-01 | 2015-06-16 |
| NCT02209909 | Coronary Artery Disease | Drug: aspirin continuation|Drug: aspirin discontinuation | Seoul National University Hospital | | 2014-07-01 | 2016-04-20 |
| NCT02674958 | Hypertrophic Obstructive Cardiomyopathy | Drug: Aspirin | Ottawa Heart Institute Research Corporation | Phase 3 | 2016-05-01 | 2016-05-09 |
| NCT01047722 | Healthy | Drug: Aspirin ingestion followed by doing a Bleeding Volume Test|Procedure: Gatorade Placebo followed by Bleeding Volume Test. | Klein, Jeffrey A., M.D. | Phase 1 | 2010-01-01 | 2015-07-18 |
